İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2021 · article

Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells

YÖKSİS OpenAlex
Yıl2021
Atıf50OpenAlex
Atıf46Semantic Scholar · 1 etkili
Yüzdelik%86,6
FWCI2,081,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q2

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıJournal of Drug Delivery Science and Technology
  • Katalog eşleşmesi (ISSN)Journal of Drug Delivery Science and Technology
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

50atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 26 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2022 Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancerAtıf 60 · OpenAlex
  2. 2022 Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancerAtıf 60 · OpenAlex
  3. 2023 Targeted CuFe2O4 hybrid nanoradiosensitizers for synchronous chemoradiotherapyAtıf 56 · OpenAlex
  4. 2023 Targeted CuFe2O4 hybrid nanoradiosensitizers for synchronous chemoradiotherapyAtıf 56 · OpenAlex
  5. 2024 An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticlesAtıf 14 · OpenAlex
  6. 2024 An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticlesAtıf 14 · OpenAlex
  7. 2024 An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticlesAtıf 14 · OpenAlex
  8. 2024 An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticlesAtıf 14 · OpenAlex
  9. 2024 An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticlesAtıf 14 · OpenAlex
  10. 2024 An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticlesAtıf 13 · OpenAlex

Yazarlar

8
  1. HAYRETTİN TONBUL 1
  2. ADEM ŞAHİN 2
  3. Ece Tavukçuoğlu 3
  4. Sedenay Akbaş 4
  5. YEŞİM AKTAŞ 5
  6. GÜNEŞ ESENDAĞLI 6
  7. YILMAZ ÇAPAN 7
  8. GÖZDE ULTAV İNÖNÜ ÜNİVERSİTESİ 8